Article
Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.
Gut - 1 Jan 2001
Malats N, Casals T, Porta M, Guarner L, Estivill X, Real F X
Abstract excerpt
BACKGROUND: An increased risk of chronic pancreatitis has been described among carriers of the cystic fibrosis transmembrane regulator (CFTR) mutation. In addition, patients with cystic fibrosis may have a higher risk of exocrine pancreatic cancer. AIMS: To determine the prevalence of the DeltaF5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.